After a filler or botulinum toxin, the clinical record line must state six things: which product (with the name on the pack), which batch and expiry, where it was injected, how much, how it was prepared and with which technique, and what you told the patient. Everything else is commentary. You copy the product data from the pack, not from memory: memory is the weak point of a record that will be read years from now.
Below are the fields, one by one, and the reason for each. This is about what you record after treating, not about doses or technique.
Why this line is read more than any other
The rest of the record tells the story of the person. The treatment line tells what was done. If a result is disputed, if a delayed reaction appears, if a manufacturer recalls a batch, it is the first thing anyone looks for. The value of that line depends on a simple question: can whoever reads it, two years from now, tell what went into that person's face, at which point and in what quantity?
A review on the use of hyaluronic acid fillers in the Asia-Pacific region defines delayed inflammatory reactions as large, painful, erythematous nodules with oedema, appearing 14 days or more after implantation (Corduff et al., 2022 (opens in a new tab)). If something like that shows up weeks or months later, the record is the only place where product, batch and area can be found again. Nobody's memory comes into it: what you need is the line written that day.
The fields of the line, one by one
Product and manufacturer
Write the trade name as it appears on the pack, and the manufacturer. For toxin this is the most delicate point: a review on botulinum toxin recalls that for years there was confusion over the doses and potency units of two widely used type A preparations (PMC2856357 (opens in a new tab)), and the label cited above states that the units are not interchangeable. Writing «botulinum toxin, 20 units» without the product name leaves the line ambiguous for the reader.
For fillers the reason is different and simpler. A filler is not a generic substance: it is a device with a name, a manufacturer and a batch. Annex XVI of EU Regulation 2017/745 (opens in a new tab) lists among the groups of products without a medical purpose «substances, combinations of substances or elements intended to be used for facial or other dermal filling». What follows from this for those who use the product is covered in another article on the blog.
Batch and expiry
The batch is copied as printed on the pack, with the same capitals and the same hyphens. Writing «A1234-B» in one session and «A1234 B» in another produces, for a search, two different batches. The expiry must be noted alongside: without it, you cannot distinguish an administration made within the shelf life from one made after.
In Fibonacci there is the Leggi dalla confezione function: with a USB reader, with the phone camera or from a photo, the code printed on the box fills in batch and expiry and, where the product is recognised, the product too (recording a treatment). The image does not leave the device. The reason for the batch, and how to trace a batch back across all patients, is covered in the article on batch traceability.
On the Italian data front for devices: Italian Legislative Decree 137/2022, Article 15 (opens in a new tab), establishes that healthcare institutions and healthcare professionals are required to record and keep the unique device identifier (UDI) of those they have received, in accordance with provisions to be laid down by decrees of the Minister of Health. The text refers to those decrees: check on the Ministry's portal whether the one that concerns you has been adopted. In the meantime, if the pack bears a UDI, copying it next to the batch costs nothing: Fibonacci has an optional field for this.
Injection areas and points
Mark where you injected, not by generic area but by point. «Cheekbones» is ambiguous: two numbered points with the quantity beside each are not. In Fibonacci the areas are marked on a portrait or on a 3D model, with numbered dots to which the quantity is linked (treated areas). If you prefer to describe in words, write the side (right or left) and the site using the same nomenclature every time, otherwise they cannot be compared. For the point map see also the injection point map.
Technique and instrument
On each individual point, in Fibonacci you can note instrument, gauge, plane and technique, in four optional fields. Why is this information worth not leaving to memory? A review on the complications of minimally invasive aesthetic procedures discusses needle and cannula among the factors affecting the risk of ecchymosis and of incorrect placement of the product, and recalls that if a filler is placed too superficially, visible product, nodules and the Tyndall effect can appear (PMC3461789 (opens in a new tab)). You do not need to share a technical opinion: what you need is that, if a nodule appears, the record states the plane you were aiming for and the instrument you used to get there.
Quantity
The quantity per point or per area, in the unit in which you declare it (units, millilitres or vials), always the same. If the stockroom counts in vials and you write in units, the software will not do the conversion: units are not converted and, to have the correct stock, the ratio («one vial contains 100 units») is transcribed from the box when the stock is loaded (stock).
Dilution and preparation
For toxin, the dilution is part of the data. The American label we use as an example describes the preparation as follows: reconstitute the vial with sterile 0.9% sodium chloride, without preservatives, choose the volume of diluent according to a table giving the units per 0.1 mL, note the date and time of reconstitution on the label, administer within 24 hours. The vials are single-dose and the remainder is discarded. This is not a protocol for you: the package leaflet of the product you use may say otherwise. The point for the record is that diluent, volume and time are three facts, and that the label itself asks you to note the date and time.
The software merely records: it calculates nothing on these fields, the declared dilution is written as it is, and if a value appears inconsistent a warning appears but saving is not blocked. This is a choice: software that refuses to record what was done produces records that do not match reality.
Anaesthetic and other drugs
If you used a local anaesthetic or anything else, write which one and, if there is a batch, that too. The same review on complications, discussing vascular risk with fillers, lists among the measures to reduce it also not using anaesthesia with epinephrine near a vascular bundle. No judgement is made here about any choice: what is needed is that the record allows reconstruction of what was injected besides the product. If your form has no dedicated field, use the session notes.
Off-label use
If the product was used outside its authorised indications, in Fibonacci there is an off-label box to tick. This is one of the cases in which consent requires specific information: it is covered in the article on off-label drugs.
Instructions given and follow-up
The last thing that goes into the line is the instructions you gave the patient and the follow-up you scheduled. The most skipped phase of a visit is often the conclusion, and verbal instructions appear nowhere. Write what was said (even just «post-treatment instructions given, verbally and in writing») and when the follow-up is. How to record the follow-up is in the article on follow-up after treatment.
An example of a line
Entirely fictitious data, to show the form. These are not dose indications, nor a way of treating.
| Field | Fictitious example | Where you take it from |
|---|---|---|
| Date and time | 12/03/2026, 10:30 | The moment of treatment |
| Patient | Example patient A | The record card |
| Product, manufacturer | «Product Alpha» (toxin), Example Company | The pack |
| Batch, expiry | LOT-0000-X, 09/2027 | The pack, copied as it is |
| Preparation | One 100-unit vial, stated diluent, stated reconstitution time | What you did, and the label |
| Points and quantity | Point 1: left, quantity; point 2: right, quantity | The point map |
| Technique | Needle, gauge, plane as per your choice | Your choice, written down |
| Other drugs | Local anaesthetic (if used) | What you used |
| Instructions | Given verbally and in writing, follow-up scheduled | What you said |
The Code of Medical Ethics (opens in a new tab) (art. 26) requires that corrections to the record be justified and signed. A saved session, in Fibonacci, can be edited: the edit remains in the history with who made it and when, and nothing is overwritten silently. From the session line you download the file as a PDF with product, batch, expiry, quantity, areas, technique, consents, photos and accesses. If the session has an anomaly, from the same line you record the complication, which remains linked to that product and that batch.
The mistakes seen most often
- The batch left blank «because it is always the same». This is the case where the batch matters most, and it is not there.
- The expiry forgotten. Without it, you cannot distinguish an administration within shelf life from one beyond it.
- Areas described in words. «Forehead, glabella and cheekbones» says neither how many points nor how much per point.
- The treatment recorded the next day. The date can be corrected, but wrong dates are only noticed in the event of a dispute.
The rules on consent are in consent for every treatment. For the legal reading on traceability there is the page product traceability, and for the one on the record incomplete record. The short list to keep in the practice is in the guide what to write in the record after a filler or a toxin.




